Fort Monroe Test Facility.

Mode of access: Internet.

Truck transport of hazardous chemicals : phosphorus pentasulfide.

Shipping list no.: 97-0029-P.

The US position in world markets.

"ER 79-10305."

Career opportunities.

Cover title.

UFAS accessibility checklist /

"June 1990."

Summary of selected injury experience and worktime for the mining industry in the United States, 1931-77 /

Chiefly tables.

Catalog of consumer and professional education materials on high blood pressure /

Cover title.

Development of test items for the entry-level social worker class in selected State and local jurisdictions /

Photocopy. Springfield, Va. : U.S. Dept. of Commerce, National Technical Information Service, 1977. -- v, 74 leaves ; 28 cm.

Morbidity and mortality weekly report. MMWR. Surveillance summaries /

Title from cover.

Further infrared systems studies for the Earth Resources Program,

Photocopy.

Designers' operating criteria : McPhee Powerplant, Dolores Project, Colorado.

"January 1990."

Home of Franklin D. Roosevelt : Roosevelt-Vanderbilt sites, Hyde Park, New York /

"Written 1989."

Ports of Miami, Port Everglades, Palm Beach, and Port Canaveral, Florida /

Includes index.

Powered microdebridement treatment for recurrent respiratory papillomatosis

Laryngeal papillomatosis is a benign disease of lhe larynx caused by human papilloma virus. The disease has u variable clinical course and treatment focuses on debridement until clinical remission. The most common technique for removing the papilloma is by carbon dioxide laser ublution. Powered microdebridement. which is more familiar to endoscopic sinus surgeons, has been adapted for use in the larynx. We would like to report on this technique for removal of respiratory papillomas that we believe to be safer for both patients and staff. The cases of seven paediatric patients with recurrent respiratory papillomatosis treated with microdebridement of their papillomas have been retrospectively reviewed.

Lessons in ethnonephrology

Only recently has the nephrology community moved beyond a fairly singular focus on terminal kidney failure to embrace population-based studies of earlier stages of disease, its markers and risk factors, and of interventions. Observations in developing countries, and in minority, migrant, and disadvantaged groups in westernized countries, have promoted these developments. We are only beginning to interpret renal disease in the context of public health history, social and health transitions, changing population demography, and competing mortality. Its intimate relationships to other health issues are being progressively exposed. Perspectives on the multideterminant etiology of most disease and the pedestrian nature of most risk factors are maturing. We are challenged to reconcile epidemiologic patterns with morphology in diseased renal tissue, and to consider structural markers, such as nephron number and glomerular size, as determinants of disease susceptibility. New work force models are mandated for population-based studies and intervention programs. Intervention programs need to be integrated with other chronic disease initiatives and nested in a matrix of systematic primary care, and although flexible to changing needs, must be sustained over the long term. Cross-disciplinary collaboration is essential in designing those programs, and in promoting them to health-care funders. Substantial expansion and restructuring of the discipline is needed for the nephrology community to participate effectively in those processes.